During the past decade, General Hospital of Xuzhou Mining Group conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "General Hospital of Xuzhou Mining Group" #1 sponsor was "Beijing Northland Biotech. Co., Ltd." with 2 trials, followed by "Capital Medical University" with 2 trials sponsored, "Beijing Tiantan Hospital" with 1 trials sponsored, "Newsoara Biopharma Co., Ltd." with 1 trials sponsored and "Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital of Xuzhou Mining Group" #1 collaborator was "Affiliated Hospital of North Sichuan Medical College" with 2 trials as a collaborator, "Anshan Central Hospital" with 2 trials as a collaborator, "Baotou Central Hospital" with 2 trials as a collaborator, "Beijing Chao Yang Hospital" with 2 trials as a collaborator and "Beijing Geriatric Hospital" with 2 trials as a collaborator. Other collaborators include 120 different institutions and companies that were collaborators in the rest 69 trials.

According to Clinical.Site data, the most researched conditions in "General Hospital of Xuzhou Mining Group" are "Arterial Occlusive Disease" (2 trials), "Familial Alzheimer Disease (FAD)" (2 trials), "Ischemia" (2 trials), "Peripheral Vascular Disease" (2 trials) and "Ulcers" (2 trials). Many other conditions were trialed in "General Hospital of Xuzhou Mining Group" in a lesser frequency.

Most popular intervention types in "General Hospital of Xuzhou Mining Group" are "Drug" (3 trials), "Genetic" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "NL003" (2 trials), "Normal Saline" (2 trials), "LB1148" (1 trials), "Placebo" (1 trials) and "SAF-189s" (1 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital of Xuzhou Mining Group" are 7 trials for "All" genders.

Currently, there are NaN active trials in "General Hospital of Xuzhou Mining Group". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in General Hospital of Xuzhou Mining Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital of Xuzhou Mining Group, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".